Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Lymphoma × abrysvo × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 56 Vincristine 42 Etoposide 38 Doxorubicin 38 Rituximab 35 Prednisone 29 Filgrastim 29 Cytarabine 23 Biopsy 23 Radiotherapy 22 Peripheral Blood Stem Cell Transplantation 21 fludarabine phosphate 17 Prednisolone 16 Melphalan 16 Specimen Handling 15 Methotrexate 15 Magnetic Resonance Spectroscopy 15 Ifosfamide 14 Bleomycin 13 Dexamethasone 12 Carmustine 12 Cyclosporine 10 Cisplatin 10 sargramostim 9 Leucovorin 9 Vinblastine 8 Chlorambucil 7 Alemtuzumab 7 aldesleukin 6 Nivolumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡